11:25 AM EDT, 07/03/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.6% to 1,436.74 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) , which rose 5.3%, followed by electronics company Philips (PHG) and biopharmaceutical company Grifols ( GRFS ) , which increased 2.5% and and 2.3%, respectively. Biotech firm BioNTech (BNTX) was up 1.2%.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk ( NVO ) and furniture maker Natuzzi (NTZ), which lost 1.4% and 1.2% respectively. They were followed by biotech firm Evaxion Biotech ( EVAX ) and pharmaceutical company Ascendis Pharma ( ASND ) , which dropped 1.1% and 0.9% respectively.

From the UK and Ireland, the gainers were led by mining company BHP Group ( BHP ) and biotech firm Autolus Therapeutics ( AUTL ) , which increased 3.5% and 2.7% respectively. They were followed by biopharmaceutical company Verona Pharma ( VRNA ) and communications company WPP ( WPP ) , which were up 3.1% and 1.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Biodexa Pharmaceuticals ( BDRX ) , which were down 2.4% and 3.2% respectively. They were followed by cruise line operator Carnival (CUK) and biopharmaceutical company Bicycle Therapeutics ( BCYC ) , which were off 0.6% and 0.8% respectively.